Linked Life Data

19328630

Source:http://linkedlifedata.com/resource/pubmed/id/19328630

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-8-5
pubmed:abstractText
Pancreatic cancer is a disease with a high mortality rate and short survival, as a result of the high incidence of metastatic disease at diagnosis, the fulminant clinical course and the lack of successful therapeutic strategies. The administration of chemotherapeutic agents for the treatment of advanced disease has failed and currently, research focuses on the understanding of molecular pathways in order to investigate the role of targeted therapy. Trials on adjuvant and neo-adjuvant therapy of pancreatic cancer are also ongoing. This review presents the recent developments with newer chemotherapeutic and molecular-targeted agents, identifying the efforts for individualized treatment strategies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1532-1967
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
431-6
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Pancreatic cancer: current and future treatment strategies.
pubmed:affiliation
Second Department of Internal Medicine, Propaedeutic Oncology Section, Attikon University General Hospital, Rimini 1, Haidari, Athens, Greece. kpliarch@otenet.gr
pubmed:publicationType
Journal Article, Review